$962M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ASND Ascendis Pharma A/S | 206,234 | — | $55M | 5.7% |
| 2 | CELC Celcuity Inc | 500,996 | +40.0% | $52M | 5.4% |
| 3 | COGT Cogent Biosciences Inc | 1.3M | −2.5% | $50M | 5.2% |
| 4 | URGN Urogen Pharma Ltd | 1.3M | −13.4% | $48M | 5.0% |
| 5 | IMNM Immunome Inc | 2.0M | +9.0% | $43M | 4.4% |
| 6 | DNTH Dianthus Therapeutics Inc | 390,000 | −40.4% | $38M | 4.0% |
| 7 | RYTM Rhythm Pharmaceuticals Inc | 311,461 | +1.8% | $35M | 3.6% |
| 8 | ORKA Oruka Therapeutics Inc | 352,802 | +133.8% | $34M | 3.5% |
| 9 | GLUE Monte Rosa Therapeutics Inc | 1.1M | −44.6% | $27M | 2.8% |
| 10 | SNDX Syndax Pharmaceuticals Inc | 1.2M | +36.6% | $27M | 2.8% |
| 11 | ELVN Enliven Therapeutics Inc | 489,382 | — | $25M | 2.6% |
| 12 | IMVT Immunovant Inc | 619,096 | +49.5% | $24M | 2.5% |
| 13 | ERAS Erasca Inc | 1.3M | −31.8% | $23M | 2.4% |
| 14 | SGMT Sagimet Biosciences Inc | 2.9M | — | $23M | 2.4% |
| 15 | ABIVAX SA Abivax Sa | 169,593 | −43.9% | $23M | 2.3% |
| 16 | PRAX Praxis Precision Medicines I | 65,679 | −8.2% | $22M | 2.3% |
| 17 | KOD Kodiak Sciences Inc | 546,256 | −44.9% | $21M | 2.2% |
| 18 | DFTX Definium Therapeutics Inc | 400,000 | — | $19M | 2.0% |
| 19 | VCYT Veracyte Inc | 318,001 | +77.0% | $19M | 1.9% |
| 20 | GH Guardant Health Inc | 99,826 | +1.3% | $15M | 1.6% |
| 21 | CCCC C4 Therapeutics Inc | 3.0M | +58.6% | $14M | 1.5% |
| 22 | ZBIO Zenas Biopharma Inc | 509,789 | −55.1% | $13M | 1.3% |
| 23 | TRVI Trevi Therapeutics Inc | 678,095 | +32.7% | $13M | 1.3% |
| 24 | HLXC Helix Acquisition Corp Iii | 1.2M | −2.6% | $13M | 1.3% |
| 25 | ALXO Alx Oncology Hldgs Inc | 5.7M | — | $12M | 1.2% |
| 26 | MANE Veradermics Inc | 95,000 | — | $12M | 1.2% |
| 27 | XENE Xenon Pharmaceuticals Inc | 186,821 | −5.5% | $11M | 1.2% |
| 28 | AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc | 330,487 | — | $11M | 1.1% |
| 29 | BIIB Biogen Inc | 48,101 | −5.6% | $10M | 1.1% |
| 30 | ACRS Aclaris Therapeutics Inc | 1.9M | — | $10M | 1.1% |
| 31 | CERS Cerus Corp | 3.5M | +9.3% | $10M | 1.1% |
| 32 | AVTX Avalo Therapeutics Inc | 500,402 | — | $9M | 1.0% |
| 33 | BNTC Benitec Biopharma Inc | 679,826 | −5.3% | $9M | 0.9% |
| 34 | PCVX Vaxcyte Inc | 145,000 | +0.0% | $8M | 0.9% |
| 35 | WGS Genedx Holdings Corp | 122,269 | — | $8M | 0.9% |
| 36 | SVRA Savara Inc | 1.4M | −5.3% | $8M | 0.9% |
| 37 | OVID Ovid Therapeutics Inc | 3.1M | +210.1% | $8M | 0.9% |
| 38 | ORIC Oric Pharmaceuticals Inc | 738,873 | −32.8% | $8M | 0.8% |
| 39 | CMPS Compass Pathways Plc | 503,382 | +67.8% | $7M | 0.7% |
| 40 | CGEN Compugen Ltd | 3.2M | −4.0% | $7M | 0.7% |
| 41 | SLDB Solid Biosciences Inc | 668,450 | — | $7M | 0.7% |
| 42 | IBIO Ibio Inc | 3.5M | +1457.7% | $6M | 0.6% |
| 43 | IRON Disc Medicine Inc | 82,800 | −57.8% | $6M | 0.6% |
| 44 | ALKS Alkermes Plc | 113,494 | −75.3% | $6M | 0.6% |
| 45 | SYRE Spyre Therapeutics Inc | 59,959 | −67.9% | $5M | 0.6% |
| 46 | ARTV Artiva Biotherapeutics Inc | 525,000 | — | $5M | 0.5% |
| 47 | CTNM Contineum Therapeutics Inc | 296,135 | −1.9% | $5M | 0.5% |
| 48 | UNIQURE NV Uniqure Nv | 105,000 | — | $5M | 0.5% |
| 49 | RACC Research Alliance Corp Iii | 360,000 | — | $4M | 0.4% |
| 50 | ABEO Abeona Therapeutics Inc | 610,407 | −5.9% | $4M | 0.4% |